SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-14-019846
Filing Date
2014-05-09
Accepted
2014-05-09 14:45:49
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP 10-Q 3-31-2014 form10q.htm 10-Q 383025
2 EXHIBIT 31 ex31.htm EX-31 11754
3 EXHIBIT 32 ex32.htm EX-32 5540
  Complete submission text file 0001140361-14-019846.txt   2843124

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20140331.xml EX-101.INS 277026
5 XBRL TAXONOMY EXTENSION SCHEMA bstc-20140331.xsd EX-101.SCH 23963
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20140331_cal.xml EX-101.CAL 37744
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20140331_def.xml EX-101.DEF 64482
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20140331_lab.xml EX-101.LAB 308328
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20140331_pre.xml EX-101.PRE 178841
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 14828527
SIC: 2834 Pharmaceutical Preparations